Anal carcinoma, version 2.2018: Clinical Practice Guidelines in Oncology Journal Article


Authors: Benson, A. B. 3rd; Venook, A. P.; Al-Hawary, M. M.; Cederquist, L.; Chen, Y. J.; Ciombor, K. K.; Cohen, S.; Cooper, H. S.; Deming, D.; Engstrom, P. F.; Grem, J. L.; Grothey, A.; Hochster, H. S.; Hoffe, S.; Hunt, S.; Kamel, A.; Kirilcuk, N.; Krishnamurthi, S.; Messersmith, W. A.; Meyerhardt, J.; Mulcahy, M. F.; Murphy, J. D.; Nurkin, S.; Saltz, L.; Sharma, S.; Shibata, D.; Skibber, J. M.; Sofocleous, C. T.; Stoffel, E. M.; Stotsky-Himelfarb, E.; Willett, C. G.; Wuthrick, E.; Gregory, K. M.; Freedman-Cass, D. A.
Article Title: Anal carcinoma, version 2.2018: Clinical Practice Guidelines in Oncology
Abstract: The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care. © JNCCN—Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 16
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2018-07-01
Start Page: 852
End Page: 871
Language: English
DOI: 10.6004/jnccn.2018.0060
PROVIDER: scopus
PUBMED: 30006428
DOI/URL:
Notes: Review -- Export Date: 1 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz
Related MSK Work